Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Calithera Biosciences Inc. (CALA)

5.73   0.01 (0.17%) 05-24 16:00
Open: 5.75 Pre. Close: 5.72
High: 5.88 Low: 5.66
Volume: 59,763 Market Cap: 225M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.883 - 5.912 5.912 - 5.941
Low: 5.593 - 5.622 5.622 - 5.652
Close: 5.682 - 5.729 5.729 - 5.777

Technical analysis

as of: 2019-05-26 10:09:36 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.11     One year: 7.53
Support: Support1: 5.50    Support2: 4.58
Resistance: Resistance1: 6.09    Resistance2: 6.45
Pivot: 5.92
Moving Average: MA(5): 5.82     MA(20): 5.97
MA(100): 5.61     MA(250): 5.18
MACD: MACD(12,26): -0.12     Signal(9): -0.11
Stochastic oscillator: %K(14,3): 31.23     %D(3): 37.08
RSI: RSI(14): 42.16
52-week: High: 6.90  Low: 3.55  Change(%): 9.1
Average Vol(K): 3-Month: 16911  10-Days: 11754

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CALA has closed above bottom band by 29.6%. Bollinger Bands are 7.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 14 May 2019 18:09:40 Z
Calithera Biosciences, Inc. (CALA) Q1 2019 Earnings Call Transcript

Thu, 02 May 2019 17:18:07 Z
Analysts Estimate Calithera (CALA) to Report a Decline in Earnings: What to Look Out for

Thu, 28 Mar 2019 00:14:13 Z
Calithera (CALA) Initiates Phase I/II Study of Telaglenastat

Mon, 11 Mar 2019 21:06:49 Z
Noteworthy Monday Option Activity: CALA, CTXS, ADBE

Thu, 08 Nov 2018 03:55:25 Z
Calithera (CALA) Reports Q3 Loss, Lags Revenue Estimates

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39.24
Shares Float (M) 39.09
% Held by Insiders
% Held by Institutions 83.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.490
EPS Est. Current Year -0.810
EPS Est. Next Year -1.050
EPS Est. Next Quarter -0.230
Forward EPS -1.879
Book Value (p.s.) 2.120
PEG Ratio -0.04
Profit Margin
Operating Margin -397.73
Return on Assets (ttm) -44.2
Return on Equity (ttm) -54.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -70.51
Levered Free Cash Flow (M) -47.19

Stock Valuations

P/E -3.85
P/E Growth Ratio
P/BV 2.70
P/S 488793920.00
P/CF -3.19

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-09-19
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.